ACHC Home Infusion Therapy Accreditation Consulting
CMS-Approved Deeming Authority for Home Infusion Therapy Providers
What Is ACHC Home Infusion Therapy Accreditation?
ACHC Home Infusion Therapy Accreditation is a CMS-approved accreditation program for providers delivering intravenous medications, biologics, and other infusion therapies in the home setting. Home infusion therapy providers — including home infusion pharmacies and specialty infusion organizations — can obtain CMS deemed status through ACHC accreditation, satisfying the Medicare Conditions of Participation without a separate CMS survey. The Medicare home infusion therapy benefit, established under the 21st Century Cures Act and effective January 1, 2021, requires that home infusion therapy suppliers be accredited by a CMS-approved accreditor for services to be covered under Medicare Part B.
Integral Healthcare Solutions (IHS) provides expert consulting to home infusion providers seeking initial ACHC accreditation, preparing for recertification, or resolving post-survey deficiencies. IHS is led by Thomas G. Goddard, JD, PhD, former Chief Operating Officer and General Counsel of URAC, with deep expertise in pharmacy accreditation, Medicare regulatory requirements, and specialty drug program compliance.
Why ACHC Accreditation Is Essential for Home Infusion Providers
- Medicare Part B Coverage Prerequisite: The 21st Century Cures Act home infusion therapy benefit requires CMS-approved accreditation for supplier enrollment and reimbursement. Unaccredited providers cannot bill Medicare for home infusion therapy services.
- CMS Deemed Status: ACHC accreditation substitutes for CMS surveys under the Medicare home infusion therapy Conditions of Participation.
- Payer Network Access: Commercial health plans, PBMs, and specialty pharmacy benefit managers require accreditation for network participation in home infusion programs.
- Pharmacy Licensing Alignment: Many state boards of pharmacy recognize ACHC accreditation as evidence of compliance with sterile compounding and specialty pharmacy standards, simplifying multi-state licensure processes.
- Patient Safety Framework: Home infusion involves high-risk medications administered in uncontrolled environments. ACHC's standards create a safety framework that reduces adverse drug events, catheter-related infections, and home-visit complications.
- Referral Source Requirements: Hospitals, oncology practices, infusion suites, and specialty physicians increasingly require ACHC accreditation as a condition for preferred provider or discharge referral relationships.
Medicare Home Infusion Therapy Benefit and ACHC Standards
The Medicare home infusion therapy benefit covers professional services associated with the administration of covered infusion drugs in the home under 42 CFR Part 486, Subpart I. The Conditions of Participation require CMS-approved accreditation as a condition of enrollment. ACHC's Home Infusion Therapy standards address all CoP domains and layer additional quality requirements that reflect the complexity of home-based infusion care.
Core CoP and ACHC Standards Domains
- Patient Assessment and Care Planning: Comprehensive admission assessment, individualized care plan development, and ongoing monitoring requirements
- Drug Therapy Management: Pharmacist oversight, drug utilization review, therapeutic monitoring, and adverse event reporting
- Nursing Services: RN assessment and patient/caregiver training requirements for self-administration programs
- Delivery and Supply Chain: Drug preparation, packaging, labeling, and temperature-controlled delivery standards
- Patient and Caregiver Training: Documentation that patients and caregivers are competent to manage infusion therapy between nursing visits
- Emergency Protocols: 24/7 clinical support, adverse event response, and emergency access to prescribers
- Infection Prevention: Catheter care protocols, aseptic technique standards, and infection surveillance
- Quality Assessment and Performance Improvement: QAPI program with home infusion-specific indicators including infection rates, adverse drug events, and rehospitalization
IHS Consulting Approach for Home Infusion ACHC Accreditation
Phase 1: Therapy Category and Standards Mapping
Home infusion providers typically offer multiple therapy categories — anti-infective, total parenteral nutrition (TPN), biologics, chemotherapy, pain management, and others — each with distinct safety and monitoring requirements. IHS begins by mapping the provider's therapy portfolio to applicable ACHC standards and identifying category-specific requirements that must be addressed.
Phase 2: Comprehensive Gap Analysis
IHS conducts a standard-by-standard gap analysis covering all ACHC Home Infusion Therapy domains. Special attention is given to pharmacist oversight documentation, nursing visit frequency and documentation, patient training competency assessment, and 24/7 clinical support infrastructure.
Phase 3: Policy and Clinical Protocol Development
IHS develops or revises policies and clinical protocols across all therapy categories. Home infusion policies must address therapy-specific monitoring parameters, adverse event recognition and response, and clinical decision support tools — all of which must be tested operationally, not just written.
Phase 4: Quality and Safety Program Review
IHS reviews the provider's infection surveillance program, adverse event reporting system, and QAPI infrastructure. Home infusion accreditation surveys place particular emphasis on catheter-related bloodstream infection (CRBSI) rates, adverse drug events, and unplanned rehospitalization — all of which require active monitoring and documented improvement activity.
Phase 5: Mock Survey and RFI Support
IHS conducts a mock survey replicating ACHC's home infusion survey process and provides targeted RFI response support for any post-survey deficiencies.
Common ACHC Home Infusion Therapy Survey Deficiencies
- Patient Training Documentation: Inadequate documentation that patients and caregivers have demonstrated competency to manage infusion therapy between nursing visits.
- Pharmacist Oversight: Missing drug utilization review documentation, therapeutic monitoring records, or pharmacist-to-prescriber communication logs.
- 24/7 Support Verification: Inability to document that 24/7 clinical support is actually available, not just claimed in policy.
- Infection Surveillance: No active CRBSI surveillance program, or surveillance data not trending over time.
- Delivery Documentation: Temperature monitoring logs missing, delivery ticket discrepancies, or chain-of-custody gaps for controlled substances.
- Adverse Event Reporting: No documented system for capturing, investigating, and reporting adverse drug events.
- QAPI Program: Home infusion-specific indicators not included, or quality data not reviewed at required intervals.
ACHC Home Infusion Therapy Accreditation Timeline
- Months 1-2: Therapy category mapping, gap analysis, remediation planning
- Months 2-5: Policy and protocol development, training system improvements, infection surveillance build
- Months 5-7: Mock survey, corrective action
- Months 7-9: ACHC application, survey scheduling, day-of support
- Post-survey: RFI response if needed, accreditation award
Why Home Infusion Providers Choose IHS
- Pharmacy Regulatory Depth: IHS works across ACHC pharmacy programs, URAC specialty pharmacy, and NABP accreditation — providing a unified perspective on pharmacy quality standards and Medicare compliance requirements.
- Medicare Benefit Expertise: IHS understands the 21st Century Cures Act home infusion benefit and CMS enrollment requirements, not just the ACHC accreditation standards.
- Multi-Therapy Experience: IHS has worked with providers across the full home infusion therapy spectrum, from anti-infectives and TPN to biologics and specialty injectables.
- Accreditation Body Insight: Thomas G. Goddard, JD, PhD's experience as COO and General Counsel of URAC informs IHS's understanding of how accreditation surveyors evaluate complex clinical programs.
Schedule a Free Discovery Session
Whether you are pursuing initial ACHC Home Infusion Therapy Accreditation for Medicare enrollment, preparing for recertification, or managing a post-survey RFI, IHS can provide experienced guidance. The first conversation is free and specific to your therapy portfolio and situation.
Schedule a Free Discovery Session